An FDA Shortcut Has Helped Drugmakers Reap Billions

The FDA’s accelerated approval pathway allows the agency to quickly approve a new drug if early study results look promising. That can come as a relief to patients and families desperate for new options. But critics say regulators haven’t done enough to force companies to produce conclusive data.